Age 70 identified as cutoff for chemotherapy benefit in colorectal cancer

Colorectal cancer remains a leading cause of cancer death, with incidence rising among older adults. One of the most pressing clinical questions has been whether elderly patients should receive oxaliplatin, a standard component of adjuvant chemotherapy that is known to cause serious side effects.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup